Profile
AKAN ZTS TAK HLN TEVA ITCI
Company Name Akanda Corp. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Intra-Cellular Therapies, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $2.38M $73.61B $47.68B $46.95B $17.60B $13.95B
Employees 0.05K 13.80K 49.28K 25.41K 33.89K 0.86K
CEO Ms. Katharyn Field Ms. Kristin C. Peck Mr. Christophe Weber Mr. Brian James McNamara Mr. Richard D. Francis Dr. Sharon Mates Ph.D.
Ratings
AKAN ZTS TAK HLN TEVA ITCI
Quant Rating Score 2 3 3 2 1 1
Quant Rating Sell Neutral Neutral Sell Strong Sell Strong Sell
Trading
AKAN ZTS TAK HLN TEVA ITCI
Last Close $1.44 $164.39 $14.9 $10.39 $16.1 $131.24
High 52 $4.11 $196.48 $15.17 $10.69 $22.77 $131.28
Low 52 $0.09 $145.54 $12.6 $8.01 $12.78 $64.37
Price vs. 52 Week High -64.96 % -16.33 % -1.78 % -2.81 % -29.29 % -0.03 %
Price vs. 52 Week Low 1500 % 12.95 % 18.25 % 29.71 % 25.98 % 103.88 %
Total Return
AKAN ZTS TAK HLN TEVA ITCI
1 Month Return -16.28 % -5.46 % 12.37 % 5.38 % -1.47 % 2.56 %
3 Month Return -3.36 % -7.74 % 11.03 % 6.45 % -2.42 % 58.06 %
6 Month Return 24.14 % -13.8 % 0.54 % 0.1 % -10.61 % 74.47 %
9 Month Return -41.22 % -6.52 % 11.69 % 24.88 % -6.5 % 92.43 %
YTD Return -10 % 0.9 % 12.54 % 8.91 % -26.95 % 57.14 %
1 Year Return 787.79 % -9.35 % 3.69 % 19.98 % 19.35 % 103.88 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AKAN ZTS TAK HLN TEVA ITCI
Dividend Yield Percentage (TTM) - 1.09 % 4.28 % 0.02 % - -
Dividend Paid and Capex Coverage Ration (TTM) -2.37 % 2.05 % 1.76 % - 2.5 % -227.26 %
Dividend Per Share (TTM) - 1.8 % 192 % 0.06 % - -
Payout Ratio (TTM) - 31.62 % 145.09 % - - -
Profitability
AKAN ZTS TAK HLN TEVA ITCI
Gross Profit Margin TTM -77.7 % 69.85 % 54.74 % 61.06 % 48.74 % 91.63 %
Return on Assets TTM -291.81 % 17.46 % 1.38 % 3.62 % -4.17 % -5.46 %
Return on Equity TTM -7846.28 % 49.65 % 2.83 % 7.27 % -26.15 % -7.4 %
Return on Capital Employed TTM -144.04 % 24.27 % 3.62 % 7.66 % -1.14 % -10.05 %
Net Income Per EBT TTM 101.61 % 79.35 % 89.75 % 67.34 % 127.75 % 100.64 %
EBT Per Ebit TTM 434.74 % 119.26 % 49.18 % 84.34 % 423.43 % 63.57 %
EBIT Per Revenue TTM -531.05 % 28.38 % 10.3 % 18.92 % -1.83 % -17.15 %
Cash Flow To Debt Ratio TTM -849.61 % 43.79 % 22.2 % - 6.9 % -430.93 %
Receivables Turnover TTM 3.98 7.03 6.23 5.26 5.41 4.09
Payables Turnover TTM 0.62 6.45 4.5 1.22 3.85 2.18
Inventory Turnover TTM - 1.21 1.66 2.99 2.82 2.17
Fixed Asset Turnover TTM 71.02 % 256.4 % 226.93 % 603.65 % 334.34 % 4569.25 %
Asset Turnover TTM 12.44 % 65.01 % 30.31 % 33.66 % 42.07 % 49.79 %
Operating Cash Flow Per Share TTM -3.37 6.5 678.77 - 1.1 -0.71
Free Cash Flow Per Share TTM -4.79 5.06 484.07 - 0.66 -0.71
Cash Per Share TTM 638.87 % 437.03 % 33271.95 % 5.75 % 291.26 % 970.67 %
Operating Cash Flow Sales Ratio TTM -256.62 % 31.9 % 23.47 % - 7.54 % -10.75 %
Free Cash Flow Operating Cash Flow Ratio TTM 142.23 % 77.82 % 71.32 % - 60.06 % 100.44 %
Cash Flow Coverage Ratios TTM -849.61 % 43.79 % 22.2 % - 6.9 % -430.93 %
Price To Free Cash Flows Ratio TTM -0.53 32.03 9.28 - 23.05 -189.86
Price To Operating Cash Flows Ratio TTM -0.5 25.28 6.61 - 13.69 -184.96
Price Cash Flow Ratio TTM -0.5 25.28 6.61 - 13.69 -184.96
Income Statement (TTM)
AKAN ZTS TAK HLN TEVA ITCI
Revenue $0B $9.26B $4263.76B $11.3B $16.54B $0.68B
Gross Profit $0B $6.54B $2832.26B $6.96B $8.06B $0.62B
Gross Profit Ratio 5.2% 70.62% 66.4% 61.59% 48.74% 91.63%
EBITDA $-0.03B $3.86B $874.6B $2.35B $-0.3B $-0.12B
Net Income $-0.03B $2.49B $144.07B $1.05B $-1.64B $-0.07B
EPS Diluted -7.16 5.47 91.16 0.11 -1.45 -0.72
Balance Sheet (MRQ)
AKAN ZTS TAK HLN TEVA ITCI
Long Term Debt $0B $5.39B $5029.93B $8.8B $16.3B $0.01B
Total Liabilities $0.01B $9.47B $7834.79B $17.33B $33.61B $0.22B
Total Equity $-0B $4.77B $7274.01B $16.73B $5.72B $1.15B
Total Investments $0B $0B $445.7B $0.07B $0B $0.69B
Total Debt $0B $6.74B $4843.75B $9.46B $18.08B $0.02B
Total Assets $0.01B $14.24B $15108.79B $34.06B $39.33B $1.37B
Cash Flow Statement (TTM)
AKAN ZTS TAK HLN TEVA ITCI
Net Income $-0.03B $2.5B $144.07B $1.11B $-1.96B $-0.07B
Inventory $0B $-0.04B $-115.74B $-0.13B $0.17B $-0.01B
Dividends Paid $0B $-0.79B $-287.19B $-0.39B $0B $0B
Operating Cash Flow $-0B $2.95B $716.34B $2.1B $1.25B $-0.07B
Capital Expenditure $-0B $-0.66B $-480.73B $-0.34B $-0.5B $-0B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.485
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 11.44
ALVOW Alvotech 1.5
AMPH Amphastar Pharmaceuticals, Inc. 26.975
AMRX Amneal Pharmaceuticals, Inc. 8.85
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 62.645
AQST Aquestive Therapeutics, Inc. 2.65
ASRT Assertio Holdings, Inc. 0.765
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 7.855
AYTU Aytu BioPharma, Inc. 1.27
BDSI BioDelivery Sciences International, Inc. 5.59
ETFs With Exposure to AKAN
Ticker ETF Name Weight Percentage Price
MJ ETFMG Alternative Harvest ETF 0 20.53
Unlock